CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 202 enrolled
Drug / intervention
Percutaneous coronary interventiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01531725
NCT01531725N/ACompleted

6 Months Evaluation of the BIOTRONIK PRO-Kinetic Coronary Stent System

Biotronik AG·interventional·Posted Feb 13, 2012·Updated Mar 25, 2013

In Brief

A clinical study evaluating Percutaneous coronary intervention for Coronary Artery Disease. Completed, enrolled 202 participants.

Detailed Summary

The primary objective of this study is to evaluate safety and efficacy of the BIOTRONIK PRO-Kinetic coronary CoCr-stent in patients with single de novo lesions of native coronary arteries.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 13, 2012
Enrollment StartFeb 1, 2007
Primary CompletionApr 1, 2008
Study CompletionMar 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 14.4 years ago

Interventions

Percutaneous coronary interventiondevice

Percutaneous coronary intervention